Nano-decocted ferrous polysulfide coordinates ferroptosis-like death in bacteria for anti-infection therapy
Nano-decocted ferrous polysulfide coordinates ferroptosis-like death in bacteria for anti-infection therapy
复制标题
纳米煎煮的多硫化亚铁协调细菌铁死亡样死亡用于抗感染治疗
DOI:
10.1016/j.nantod.2020.100981
复制
发表时间:
2020-12-01
期刊:
影响因子:
17.4
通讯作者:
Gao, Lizeng
中科院分区:
文献类型:
--
作者:
Shen, Xinyu;Ma, Ruonan;Gao, Lizeng
Antibacterial nanomaterials provide promising alternative strategies to combat the global challenge of bacterial infection due to deteriorating resistance. However, few have been applied for intracellular bacteria killing or in vivo therapy due to potential cytotoxicity and poor biocompatibility. Here we present a strategy to generate formula suitable for in vivo anti-infective therapy by decocting antibacterial nanomaterial. An aqueous formula containing ferrous iron and polysulfide (Fe(II)S(n)aq) is prepared by a decoction procedure using nano-iron sulfide (nFeS) as raw substance. Theoretical calculation indicated that replacement of a sulfur atom by an oxygen atom occurred, resulting in polysulfide release and iron dissolution. The Fe(II)S(n)aq decocted from nFeS induced bacterial death with ferroptosis-like hallmarks, including iron enrichment, lipid peroxidation, and glutathione (GSH) depletion. The antibacterial action of Fe(II)S(n)aq was dependent on ferrous iron, which could be inhibited by iron chelators, ferroptosis inhibitors, and GSH, while the polysulfide prevented ferrous iron oxidation and counteracted GSH. Furthermore, Fe(II)S(n)aq not only killed up to 99 % of planktonic bacteria within 5 min, but also suppressed up to 90 % of intracellular Staphylococcus aureus without triggering cytotoxicity to host cell. Administration of Fe(II)S(n)aq achieved equivalent therapeutic effect to vancomycin for infectious pneumonia treatment and significantly prolonged the survival period of septic mice. These results indicate that aqueous ferrous polysulfide can induce ferroptosis- like death in bacteria and may be formulated as an antibacterial alternative for anti-infection therapy. (C) 2020 The Author( s). Published by Elsevier Ltd.